Search Results - "Mazer, B. D."

Refine Results
  1. 1

    B lymphocytes in inflammatory airway diseases by Drolet, J.-P., Frangie, H., Guay, J., Hajoui, O., Hamid, Q., Mazer, B. D.

    Published in Clinical and experimental allergy (01-06-2010)
    “…Summary B lymphocytes are key players in all facets of adaptive immune responses and are responsible for the production of IgE antibodies, initiators of…”
    Get full text
    Journal Article
  2. 2

    Intravenous immunoglobulin attenuates airway hyperresponsiveness in a murine model of allergic asthma by Kaufman, G. N., Massoud, A. H., Audusseau, S., Banville-Langelier, A.-A., Wang, Y., Guay, J., Garellek, J. A., Mourad, W., Piccirillo, C. A., McCusker, C., Mazer, B. D.

    Published in Clinical and experimental allergy (01-05-2011)
    “…Summary Background Intravenous immunoglobulin (IVIG) has potent anti‐inflammatory and immune‐modulating properties. IVIG has been utilized as a steroid‐sparing…”
    Get full text
    Journal Article
  3. 3

    Signal transducer and activator of transcription 6 down-regulates toll-like receptor-4 expression of a monocytic cell line by Fiset, P. O., Tulic, M. K., Skrablin, P. S. A., Grover, S. M., Létuvé, S., Mazer, B. D., Hamid, Q.

    Published in Clinical and experimental allergy (01-02-2006)
    “…Summary Background Toll‐like receptor 4 (TLR4), part of the bacterial lipopolysaccharide (LPS) receptor, is an important bridge between innate and adaptive…”
    Get full text
    Journal Article
  4. 4

    Efficient purification of eosinophils from human tissues: A comparative study by Nissim Ben Efraim, A.H., Munitz, A., Sherman, Y., Mazer, B.D., Levi-Schaffer, F., Eliashar, R.

    Published in Journal of immunological methods (15-04-2009)
    “…Eosinophils are key effector cells in allergy and in other inflammatory diseases. Although they carry out their function in the tissues, no efficient method…”
    Get full text
    Journal Article
  5. 5

    TGF-β-mediated airway tolerance to allergens induced by peptide-based immunomodulatory mucosal vaccination by Michael, H, Li, Y, Wang, Y, Xue, D, Shan, J, Mazer, B D, McCusker, C T

    Published in Mucosal immunology (01-11-2015)
    “…We sought to modulate mucosal immune responses using neonatal vaccination to avert the development of allergic airways disease (AAD). Pulmonary pathology in…”
    Get full text
    Journal Article
  6. 6

    Functional Expression of IL-12 Receptor by Human Eosinophils: IL-12 Promotes Eosinophil Apoptosis by Nutku, Esra, Zhuang, Qianli, Soussi-Gounni, Abdelillah, Aris, Fadi, Mazer, Bruce D, Hamid, Qutayba

    Published in The Journal of immunology (1950) (15-07-2001)
    “…In murine models of allergic inflammation, IL-12 has been shown to decrease tissue eosinophilia, but the underlying mechanisms are not known. We evaluated the…”
    Get full text
    Journal Article
  7. 7

    An open-label study of high-dose intravenous immunoglobulin in severe childhood asthma by Mazer, B D, Gelfand, E W

    Published in Journal of allergy and clinical immunology (01-05-1991)
    “…Eight pediatric patients with severe steroid-dependent asthma were enrolled in an open-label trial of high-dose intravenous immunoglobulin (IVIG) in an attempt…”
    Get more information
    Journal Article
  8. 8

    Children with atopic histories exhibit impaired lipopolysaccharide-induced Toll-like receptor-4 signalling in peripheral monocytes by Préfontaine, D., Banville-Langelier, A.-A., Fiset, P.-O., Guay, J., An, J., Mazer, M., Hamid, Q., Mazer, B. D.

    Published in Clinical and experimental allergy (01-11-2010)
    “…Summary Background The hygiene hypothesis states that early exposure to bacterial products such as lipopolysaccharide (LPS) may be protective against the…”
    Get full text
    Journal Article
  9. 9

    Activation Via Multiple Signaling Pathways Induces Down-Regulation of Platelet-Activating Factor Receptors on Human B Lymphocytes by Zhuang, Qianli, Bastien, Yolande, Mazer, Bruce D

    Published in The Journal of immunology (1950) (01-09-2000)
    “…Platelet-activating factor receptor (PAFR) has been identified in B cell lines and primary human B cells, but the regulation of PAFR during B cell activation…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Similar allergic inflammation in the middle ear and the upper airway: Evidence linking otitis media with effusion to the united airways concept by Nguyen, Lily H.P., Manoukian, John J., Sobol, Steven E., Tewfik, Ted L., Mazer, Bruce D., Schloss, Melvin D., Taha, Rame, Hamid, Qutayba A.

    Published in Journal of Allergy and Clinical Immunology (01-11-2004)
    “…Otitis media with effusion (OME) is a chronic inflammatory disease of the middle ear space characterized by the accumulation of fluid. Previous investigations…”
    Get full text
    Journal Article
  12. 12

    Synthesis of IL-13 by human B lymphocytes: Regulation and role in IgE production by Hajoui, Oumnia, Janani, Ramesh, Tulic, Meri, Joubert, Philippe, Ronis, Tova, Hamid, Qutayba, Zheng, Huaien, Mazer, Bruce D.

    Published in Journal of allergy and clinical immunology (01-09-2004)
    “…Our laboratory has demonstrated previously that human tonsillar B lymphocytes express IL-13 mRNA We sought to investigate IL-13 production by human B cells and…”
    Get full text
    Journal Article
  13. 13

    Dose-dependent agonist and antagonist effects of the platelet-activating factor analogue 1-palmitoyl-2-acetoyl- sn-glycero-3-phosphocholine on B lymphocytes by Mazer, Bruce D., Toledano, Baruch, Saririan, Mehrdad, Bastien, Yolande

    Published in Journal of allergy and clinical immunology (01-08-1998)
    “…Background: Platelet activating-factor (PAF), an ether-linked phospholipid, is a potent activator of B lymphocyte cell lines. The related ester-linked…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Autocrine stimulation of B lymphocytes by platelet-activating factor receptor agonist, 1-palmitoyl-2-acetoyl-sn-glycero-3-phosphocholine by TORDAI, A, FRANKLIN, R. A, JOHNSON, C, MAZER, B. D, CLAY, K. L, GELFAND, E. W

    Published in The Journal of immunology (1950) (15-01-1994)
    “…Based on previous data which demonstrated the ability of platelet-activating factor (PAF) antagonists to inhibit constitutive immunoglobulin synthesis in…”
    Get full text
    Journal Article
  16. 16

    B-cell activation and regulation of immunoglobulin synthesis by platelet activating factor by Mazer, B D, Sawami, H, Franklin, R, Gelfand, E W

    Published in Netherlands journal of medicine (01-10-1991)
    “…Platelet activating factor (PAF) is a highly potent phospholipid mediator known to be active in many biologic systems. To date little is known of the effect of…”
    Get more information
    Journal Article
  17. 17

    An ELISA spot assay for quantitation of human immunoglobulin-secreting cells by Mazer, B D, Renz, H, Gelfand, E W

    Published in Journal of allergy and clinical immunology (01-08-1991)
    “…The elucidation of changes in populations of immunoglobulin-secreting cells has been a cumbersome process. We present a simplified method for the enumeration…”
    Get more information
    Journal Article
  18. 18

    Immune function in autistic children by Stern, Lara, Francoeur, Marie-Josée, Primeau, Marie-Noel, Sommerville, Wendy, Fombonne, Eric, Mazer, Bruce D

    Published in Annals of allergy, asthma, & immunology (01-12-2005)
    “…There have been reports that some children with autistic spectrum disorders have abnormal immune function. However, data in this area remain scarce and…”
    Get more information
    Journal Article
  19. 19
  20. 20

    Absence of ZAP-70 prevents signaling through the antigen receptor on peripheral blood T cells but not on thymocytes by Gelfand, E W, Weinberg, K, Mazer, B D, Kadlecek, T A, Weiss, A

    Published in The Journal of experimental medicine (01-10-1995)
    “…Recently, a severe combined immunodeficiency syndrome with a deficiency of CD8+ peripheral T cells and a TCR signal transduction defect in peripheral CD4+ T…”
    Get full text
    Journal Article